Monophasic formulations by Revitrane are based on high-quality, stabilized hyaluronic acid that is cross-linked in a single step. The innovative CPMCPM technology (Cohesive Polydensified Matrix) creates a highly moldable gel with homogeneous distribution, low viscosity, and high stability. The double cross-linking process at low temperature results in a biocompatible, resilient structure that allows for even intradermal application and long-lasting, natural results with a high level of safety.